Today: 27 June 2026
Cummins stock jumps 4% after Raymond James hikes target — here’s what traders are watching
9 February 2026
1 min read

Cummins stock jumps 4% after Raymond James hikes target — here’s what traders are watching

New York, February 9, 2026, 15:10 EST — Regular session

  • Cummins jumped roughly 4% in afternoon trading, after Raymond James raised its price target to $675.
  • Investors are sizing up demand for data-center backup power, even as the North American truck cycle remains uneven.
  • Attention shifts to Cummins’ Analyst Day on May 21, where investors are looking for specifics on capacity, capital outlays, and plans for returning value to shareholders.

Shares of Cummins Inc (CMI) jumped 4.1% to $601.57 as of 2:55 p.m. EST on Monday. The move followed a price target hike from Raymond James for the engine and power-generation company.

Cummins is caught between two identities in the market right now—truck-cycle gauge on one hand, data-center power player on the other—especially after last week’s results. Shares remain close to their highs, so even minor tweaks to outlook or valuation are nudging the stock.

Raymond James bumped its price target up to $675 from $585 while sticking with an “Outperform” call, citing a rebound in North American on-highway markets and ongoing strength from global data center growth. The firm’s report also mentioned that buybacks could be back on the table in 2026 as balance sheet constraints start to ease. Investing.com

Cummins on Feb. 5 called for 2026 revenue to increase between 3% and 8%, with EBITDA expected to come in at 17% to 18% of sales. For the fourth quarter, sales were $8.536 billion. Diluted earnings landed at $4.27 per share, reflecting charges from a strategic review of the Accelera electrolyzer business.

On the earnings call, chief executive Jennifer Rumsey said the company is “taking orders now well into 2028” for diesel backup power—demand that’s getting a boost from data-center expansion. Chief financial officer Mark Smith flagged that the existing tariff regime stands to shave around 50 basis points, or half a percentage point, off annual margins if it stays in place. Reuters

But it’s hardly a straightforward bet. Everything hinges on a rebound in North American truck demand later this year—if freight weakens, engine orders could fall off quickly. There’s also the question of Cummins: is the company’s recent step back from electrolyzers just a blip, or should investors brace for a wider slowdown in its hydrogen ambitions?

Cummins surged past several industrial peers on Monday. Caterpillar gained ground, but shares of truck manufacturer Paccar barely moved, even as the wider U.S. market advanced.

May 21 in New York marks Cummins’ Analyst Day—the next critical checkpoint for investors. The company’s promised deeper dives into strategy are in focus. Power systems capacity, spending at Accelera, and management’s stance on capital returns will be scrutinized for clarity by traders.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Wait 90 Days Before Buying More SpaceX Stock Due to Upcoming Share Unlocks
    June 27, 2026, 12:00 PM EDT. Space Exploration Technologies (SpaceX) recently made a record-breaking $75 billion initial public offering (IPO), valuing the company at $1.77 trillion. Although its stock briefly surged, it has dropped 3% since debut. Investors should consider waiting 90 days before buying more shares due to an upcoming lockup period, during which insiders are restricted from selling. After this period, additional shares will enter the market, potentially pressuring the stock price downward. SpaceX only floated about 4% of shares initially, with gradual increases expected over time. Historically, blockbuster IPOs often underperform in their first years, so patience and reassessment after the lockup expiration in September is advised to gauge true market response and valuation.

Latest articles

PayPal stock surge shifts short-interest story into next week

PayPal stock surge shifts short-interest story into next week

27 June 2026
PayPal surged 4.5% to $44.29 Friday on trading volume more than double its 65-day average, following a 9.7% jump in short interest to 54.35 million shares as of June 15, equal to 6.2% of float; despite the rally, shares remain 44% below last year’s high, with the stock still seen as a turnaround play and a shortened trading week ahead due to the July 3 U.S. holiday.
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data
Previous Story

US Economic Calendar Today: Stock Futures Hold Steady as Traders Eye Fed Speeches, Treasury Buyback and Delayed Jobs Data

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Next Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Go toTop